Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06431074 · ClinicalTrials.gov registry record · NA
Radicle Calm 24: A Study of Health and Wellness Products on Feelings of Anxiety and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 502
- Enrollment target
NCT06431074: Completed NA study, sponsored by Radicle Science.
NCT06431074 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 502 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06431074, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 502 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on feelings of anxiety and related health outcomes
Primary Outcome
Mean difference in feelings of anxiety score as assessed by Patient Reported Outcome Measurement System (PROMIS) Anxiety 8A (scale 8-40; where lower scores correspond to less feelings of anxiety)
Interventions
- DIETARY_SUPPLEMENT Placebo Control Form 1
- DIETARY_SUPPLEMENT Calm Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Placebo Control 6.1
- DIETARY_SUPPLEMENT Calm Active Study Product 6.1 Usage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 502 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2025-08-11 |
| Phase | NA |
What the finished NCT06431074 record still lists
NCT06431074 is an interventional study that assigns participants to a tested intervention. The registered 502 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo Control Form 1 is the first listed.
NCT06431074 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06431074 about?
NCT06431074 is a clinical study titled "Radicle Calm 24: A Study of Health and Wellness Products on Feelings of Anxiety and Related Health Outcomes". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on feelings of anxiety and related health outcomes
What is the current status of trial NCT06431074?
This trial is currently completed. It is a NA study. The enrollment target is 502 participants. The study started on 2024-05-30. Estimated completion is 2025-08-11.
What interventions are being tested in trial NCT06431074?
The interventions under investigation include: Placebo Control Form 1 (DIETARY_SUPPLEMENT), Calm Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Placebo Control 6.1 (DIETARY_SUPPLEMENT), Calm Active Study Product 6.1 Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06431074?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06431074's enrollment target sits among peer trials
502 193rd of 2000 higher than 1,808 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- NCT05143931 · 503 participants · NA
Avoid and Resist Strategies for Weight Management
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI